The objectives of today’s presentation will include:

1. A review of US Cervical Cancer Screening Practice.
   
   
2. The latest 2012 Screening Guidelines, including HPV DNA testing and testing Interval Extension.
   
   
3. The role of HPV testing in Screening as a predictor of a woman’s risk for developing cervical disease.